Add like
Add dislike
Add to saved papers

Widespread Nuclear Lamina injuries defeat proteostatic purposes of α-Synuclein amyloid Inclusions.

Biogenesis of inclusion bodies (IBs) facilitates protein quality control (PQC). Canonical aggresomes execute degradation of misfolded proteins while non-degradable amyloids quarantine into Insoluble Protein Deposits. Lewy Bodies (LBs) are filamentous amyloid inclusions of α-Synuclein but PQC-benefits and drawbacks associated with LB-like IBs remain underexplored. Here, we report that a crosstalk between filamentous LB-like IBs and aggresome-like IBs of α-Synuclein (Syn-aggresomes) buffer the load, aggregation state, and turnover of the amyloidogenic protein. Filamentous LB-like IBs possess unorthodox PQC-capacities of self-quarantining α-Synuclein amyloids and being degradable upon receding fresh amyloidogenesis. Syn-aggresomes equilibrate biogenesis of filamentous LB-like IBs by facilitating spontaneous degradation of α-Synuclein and conditional turnover of disintegrated α-Synuclein amyloids. Thus, both the inclusion bodies primarily contribute to PQC. Incidentally, the overgrown perinuclear LB-like IBs turn degenerative once these are misidentified by BICD2, a cargo-adapter for cytosolic motor-protein dynein. Microscopy indicates that microtubules surrounding the perinuclear filamentous inclusions are also distorted misbalancing the cytoskeleton-nucleoskeleton tension leading to widespread lamina injuries. Together, nucleocytoplasmic mixing, DNA-damage, and deregulated transcription of stress chaperones defeat the proteostatic purposes of the filamentous amyloids of α-Synuclein.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app